Targeted proteomics for biomarker discovery and validation of hepatocellular carcinoma in hepatitis C infected patients

doi:10.4254/wjh.v7.i10.1312

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 10

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9087)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series.

Item

Count

PDF

539

WORD

253

HTML

5555

Figures (1-2)

269

Sum=6616

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1109

Download

1362

Sum=2471

Jun 8, 2015 (publication date) through Nov 22, 2024

Times Cited of This Article

Times Cited (18)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Hepatol. Jun 8, 2015; 7(10): 1312-1324
Published online Jun 8, 2015. doi: 10.4254/wjh.v7.i10.1312

Open in New Tab Full Size Figure Download Figure

Figure 1 Proteomics strategy for biomarker discovery. HCC: Hepatocellular carcinoma; HCV: Hepatitis C virus; Cy: Cyanine; 2D-DIGE: 2D-difference in-gel electrophoresis; MS: Mass spectrometry; LC: Liquid chromatography.

Open in New Tab Full Size Figure Download Figure

Figure 2 Targeted proteomics work flow for relative and absolute quantification. SRM: Selected reaction monitoring.

Citation: Mustafa GM, Larry D, Petersen JR, Elferink CJ. Targeted proteomics for biomarker discovery and validation of hepatocellular carcinoma in hepatitis C infected patients. World J Hepatol 2015; 7(10): 1312-1324
URL: https://www.wjgnet.com/1948-5182/full/v7/i10/1312.htm
DOI: https://dx.doi.org/10.4254/wjh.v7.i10.1312